The University of California San Francisco was the first in the nation to test a groundbreaking vaccine that’s making history.

Blelloch and colleagues create genetically engineered universal human iPSCs, differentiate them into CCR7+ migratory dendritic cells, and dress them with tumor-derived MHC class I-antigen complexes to...

9th Annual Nova12SF Walk

A study found that the vast majority of veterans with early prostate cancer pursued surveillance instead of treatment.

Komen is investing in the future of breast cancer research, awarding $15.4 million to researchers working on accelerating breakthroughs.

UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute.

Frank McCormick, PhD, FRS, DSc (Hon), discussed his vision for preemptively treating KRAS-driven precancerous lesions, differences between KRAS allele subtypes, and where the field is headed over the ...

9th Annual Nova12SF Walk

FASTRO designation recognizes sustained achievement and service to radiation medicine and patient care Ke Sheng, PhD, professor and Vice Chair, Division of Physics, Department of Radiation Oncology at...

Lung cancer experts discuss the optimal management of CNS disease in EGFR-mutated non–small cell lung cancer.

Charles Craik’s entrepreneurial journey shows how curiosity-driven chemistry led to multiple biotech companies, and how tools, collaboration and unmet clinical needs shape when academic discoveries mo...